A Study on Acute Symptomatic Seizures in the Elderly. by Muthukumaran, D
A STUDY ON ACUTE SYMPTOMATIC SEIZURES IN 
THE ELDERLY  
 
 
Dissertation submitted to 
THE TAMILNADU DR.M.G.R. MEDICAL UNIVERSITY 
 
 
 
in partial fulfilment of the requirements  
for the award of the degree of 
DM (NEUROLOGY) – BRANCH – I 
 
 
 
 
 
THE TAMILNADU DR.M.G.R. MEDICAL UNIVERSITY 
CHENNAI 
 
AUGUST 2011 
 
CERTIFICATE 
        This is to certify that the Dissertation entitled, “A STUDY ON 
ACUTE SYMPTOMATIC SEIZURES IN THE ELDERLY” is the 
bonafide record work done by Dr.D.Muthukumaran, under our guidance 
and supervision in the Institute of Neurology, Rajiv Gandhi Government 
General Hospital, Madras Medical College, Chennai, submitted as partial 
fulfilment for the requirements of D.M. Degree examination Branch I 
NEUROLOGY, AUGUST 2011, under The Dr.M.G.R. Medical 
University, Chennai. 
 
DR.R.M.BHOOPATHY .DM.                                                                                
PROFESSOR  OF NEUROLOGY,                                                                              
INSTITUTE OF NEUROLOGY,                                                                                           
MADRAS MEDICAL COLLEGE,                                                                                         
CHENNAI-3 
 
DR.V.SUNDAR. Mch.                                                                                           
PROFESSOR AND HEAD OF THE DEPARTMENT,                                                                              
INSTITUTE OF NEUROLOGY,                                                                                           
MADRAS MEDICAL COLLEGE,                                                                                         
CHENNAI-3 
 
 
 
Dr.V.KANAGASABAI, M.D., 
THE DEAN, 
MADRAS MEDICAL COLLEGE, 
CHENNAI-3.                                        
 
 DECLARATION 
 
 I solemnly declare that this dissertation titled “A STUDY ON 
ACUTE SYMPTOMATIC SEIZURES IN THE ELDERLY”  is done 
by me in the Institute of Neurology, Madras Medical College & Rajiv 
Gandhi Government General Hospital, Chennai under the guidance and 
supervision of Prof. Dr.R.M. Bhoopathy, M.D.,D.M., Professor of 
Neurology, Institute  of  Neurology, Madras Medical College & Rajiv 
Gandhi Government General Hospital, Chennai. This dissertation is 
submitted to the Tamil Nadu Dr.M.G.R Medical University, Chennai in 
partial fulfilment of the university requirements for the award of the degree 
of D.M. Neurology. 
 
Place : Chennai 
Date  :                                             
 
Dr.D.Muthukumaran. 
D.M.Postgraduate student, 
Institute of  Neurology,  
Madras medical college,  
Chennai.       
 
 
 
 
 
 ACKNOWLEDGEMENT 
 It gives me great pleasure to acknowledge all those who guided, 
encouraged and supported me in the successful completion of my 
dissertation. 
           First and foremost, I express my gratitude to, the Dean 
Dr.V.Kanagasabai M.D.for having permitted me to carry out this 
dissertation work at Rajiv Gandhi  Government General Hospital, Madras 
Medical College, Chennai.  
I am extremely thankful to Prof. Dr.V.Sundar.M.ch., Professor of 
Neurosurgery, Head of the department, Institute of Neurology, Rajiv 
Gandhi Government General Hospital Chennai for his constant 
encouragement, valuable guidance and support. 
 I express my deep sense of gratitude and sincere thanks to our 
respected and  beloved  Chief  Dr.  R.M. Bhoopathy. M.D.,  D.M., 
Professor of Neurology,  Institute  of  Neurology, Rajiv Gandhi 
Government General Hospital Chennai  for his teaching, valuable 
suggestions, constant motivation,  kind guidance and  moral support in the 
conduct of this study. 
          I express my sincere thanks and gratitude to our Professors    
Dr.C.Mutharasu.D.M., Dr.K.Bhanu.D.M., Dr.R.LakshmiNarasimhan.D.M,                   
Dr. S. Balasubramanian. D.M.,  for their valuable suggestions and support. 
 I express my sincere thanks to Prof. Dr. C. Rajendiran M.D., 
Director of Institute of General Medicine, Rajiv Gandhi Government 
General Hospital Chennai   for allowing me to collect the case materials 
and for his guidance. 
        I am extremely thankful to our Assistant Professors Dr.V.Kamaraj. 
D.M.,    Dr.S.Arunan..D.M.,Dr.M.Jawahar.D.M.,Dr.P.Muthukumar.D.M.,                       
Dr. V.Kannan.D.M.,  for their valuable guidance and support. 
 I owe my sincere thanks to all those patients and the technical staffs 
who participated in the study for it is their cooperation which made this 
study possible. 
 
 
CONTENTS 
S.No. Title Page No. 
1   INTRODUCTION 1 
2   REVIEW OF LITERATURE 3 
3   AIM AND OBJECTIVES 36 
4   MATERIALS AND METHODS 37 
5   RESULTS  AND ANALYSIS 39 
6   DISCUSSION 55 
7    SUMMARY 67 
8   CONCLUSION 68 
9   REFERENCES  
10   APPENDICES  
 
 LIST OF ABBREVIATIONS 
 
CNS                   -                    Central nervous system 
CT                      -                   Computerized Tomogram 
MRI                   -                    Magnetic Resonance Imaging 
EEG                   -                    Electro Encephalogram   
ILAE                  -                    International League Against Epilepsy 
GTCS                 -                    Generalized Tonic Clonic Seizure    
AED                   -                    Anti Epileptic Drug 
CSF                    -                    Cerebrospinal Fluid 
HIV                    -                    Human immunodeficiency virus 
FND                   -                    Focal neurological deficit 
ICH                    -                    Intracerebral haemorrhage 
CVT                   -                    Cerebral venous thrombosis 
GRE                   -                    Gradient echo sequence 
DWI                   -                     Diffusion weighted image 
 
1 
 
INTRODUCTION 
Acute symptomatic seizures1 are those caused or provoked by an 
acute medical or neurological insult and it is as common as epilepsy in the 
medical wards. Acute symptomatic seizures differ from epilepsy in several 
important aspects. First, unlike epilepsy, these seizures have a clearly 
identifiable proximate cause, to the extent that one can never be certain of 
a causal association. When one considers the temporal sequence of acute 
symptomatic seizures (e.g.uremia, head injury, or stroke immediately 
preceding a seizure), the biologic plausibility (acute disruption of brain 
integrity or metabolic homeostasis) and in many cases the dose effect 
(severity of injury correlated with the risk for seizures) all quite 
compellingly indicate causation. Although a risk ratio for the immediate 
association between cause and effect has not been calculated, it must be 
enormous. Second, unlike epilepsy, acute symptomatic seizures are not 
characterized by a tendency to recur. The risk for subsequent epilepsy may 
be increased in individuals experiencing such insults; in general, one does 
not expect seizures to recur unless the underlying condition recurs. As a 
corollary, such individuals usually do not need to be treated with 
antiseizure medication on a long-term basis, although such treatment may 
be warranted on a short-term basis until the acute condition is resolved2. It 
may be single or repetitive.  Type of seizure can be focal with or without 
generalisation or generalised. Most common is generalised tonic clonic 
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seizure. Non convulsive seizure and status are common in patients 
admitted to intensive care units. Partial seizure is usually associated with 
structural abnormalities of brain but generalised seizure may result from 
cellular or structural abnormalities that have a wide spread distribution. In 
developing countries most common cause of acute symptomatic seizure is 
CNS infections. Seizures in the elderly may be caused by stroke, systemic 
metabolic conditions, subdural hematoma, central nervous system 
infection, degenerative disorders, or malignancy. The etiology of seizures 
is multifactorial in any given individual and is best thought of as an 
interaction between genetically determined seizure thresholds, underlying 
predisposing pathologies or metabolic derangements and acute 
precipitating factors. Very few studies are there, analysing the causes of 
acute symptomatic seizures, in the elderly patients .  So it is useful to study 
the various conditions   producing seizures in our patients and the use of   
investigations to find out the underlying problem. A detailed medical 
history, a thorough physical examination, especially  of  the  nervous  
system, analysis of blood and other body fluids,  electroencephalographic 
(EEG) recordings, magnetic resonance imaging (MRI) and/or 
computerized tomography (CT) scans we are able to find  out the 
underlying  cause  of  acute  symptomatic seizures. Accurate  diagnosis of  
the cause of acute symptomatic seizure is very important in the treatment 
and  prognosis as the treatment of underlying condition will abolish the 
seizure .                                                                               
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REVIEW OF LITERATURE 
A seizure is a paroxysmal event due to abnormal, excessive, 
hypersynchronous discharges from an aggregate of central nervous system  
neurons. Depending on the distribution of discharges, this abnormal CNS 
activity can have various manifestations, ranging from dramatic convulsive 
activity to experiential phenomena not readily discernible by an observer.        
Although  a  variety  of  factors  influence  the  incidence   and prevalence  
of  seizures ,  5–10%  of  the  population  will  have  at least one seizure, 
with the highest incidence occurring in early childhood and late 
adulthood3,4. 
Epilepsy  describes  a  condition  in  which  a  person  has    
recurrent seizures  due  to  a  chronic ,  underlying   process . This 
definition  implies that   a person  with a  single  seizure , or  recurrent  
seizures  due  to  correctable or   avoidable   circumstances, does not 
necessarily have epilepsy. Epilepsy refers to a clinical  phenomenon  rather  
than  a  single  disease  entity ,  since  there  are many  forms  and  causes  
of  epilepsy .  However, among the many causes of   epilepsy   there   are  
various  epilepsy  syndromes  in which  the  clinical  and pathologic 
characteristics  are  distinctive  and  suggest  a  specific  underlying   
etiology.  
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Definitions of Terms 5 
              A non epileptic event is a clinical event presumed to be unrelated to 
abnormal and excessive neuronal discharge. An example of a non epileptic 
event is syncope.  
An  epileptic seizure is a clinical event presumed to result from an 
abnormal and excessive neuronal discharge. The clinical symptoms are 
paroxysmal and may include impaired consciousness and motor, sensory, 
autonomic, or psychic events perceived by the subject or an observer. 
A provoked seizure is an acute symptomatic seizure that occurs 
following a recent acute disorder such as a metabolic insult, toxic insult, 
CNS infection, stroke, brain trauma, cerebral haemorrhage, medication 
toxicity, alcohol withdrawal, or drug withdrawal. 
 An unprovoked seizure is a cryptogenic or a remote symptomatic 
seizure.  
Epilepsy occurs when 2 or more epileptic seizures occur unprovoked 
by any immediately identifiable cause. The seizures must occur more than 
24 hours apart. In epidemiologic studies, an episode of status epilepticus is 
considered a single seizure. Febrile seizures and neonatal seizures are 
excluded from this category.  
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Frequency: 
A first seizure is a sudden frightening event for the individual, 
onlookers and family members. Available data on an individual's lifetime 
risk of developing one episode of non-febrile seizures is at least 4% .6 A 
first seizure caused by an acute disturbance in brain function (acute 
symptomatic or provoked) is unlikely to recur (3 to 10 %).7 If a seizure is 
unprovoked, however, meta-analysis suggests that 30 to 50 % will recur; 
and after a second unprovoked seizure, 70 to 80 % recur, justifying the 
diagnosis of epilepsy. 8 
Sex:                                                                                                         
         Most authors report a small-to-moderate increased preponderance in 
men in their studies of first seizures in adults9  
Age 10 
In practice it is useful to consider the etiologies of seizures based on 
age of the patient, as age is one of the most important factors determining 
both the incidence and likely causes of seizures.  
Causes for seizures in Neonates: 
Perinatal hypoxia and ischemia, intracranial haemorrhage and 
trauma, acute CNS infection, metabolic disturbances, drug withdrawal, 
genetic disorders. 
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Causes for seizures in Infants and Children: 
• Febrile seizures, genetic disorders, developmental disorders, 
trauma., Idiopathic. 
Causes for seizures in Adolescents: 
• Trauma. 
• Genetic Disorders. 
• Infection. 
• Tumor. 
• Illicit drugs. 
• Idiopathic 
Causes for seizures in young adults: 
• Trauma. 
• Alcohol Withdrawal. 
• Illicit drug use. 
• Tumor. 
• Idiopathic. 
Causes for seizures in older adults: 
• Cerebrovascular disease 
• Brain tumor 
• Alcohol withdrawal 
• Metabolic disorders 
• Degenerative diseases 
• Idiopathic  
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CLASSIFICATION OF  SEIZURES  
             Seizures have been classified in several ways: according to their 
supposed etiology, i.e., idiopathic (primary) or symptomatic (secondary); 
their site of origin; their clinical form (generalized or focal);  their 
frequency (isolated, cyclic, or repetitive, or the closely spaced sequence of 
status epilepticus);  or their electrophysiologic correlates. The 
classification  of seizure  was first proposed by  Gastaut in 1970 and was 
then refined repeatedly by the Commission  on Classification and 
Terminology of the International League Against Epilepsy (1981). This 
classification, based mainly on the clinical form of the seizure and its 
electroencephalographic (EEG) features, has been adopted worldwide and 
is generally referred to as the International Classification12. A simpler 
classification system,  another ILAE classification that was developed in 
1993 for conducting epidemiological survey on epilepsy. This was named 
the Epidemiological Classification (EC) and was proposed for only 
research purposes to overcome technical problems in field studies. 1 
      An acute symptomatic seizure is defined as a clinical seizure 
occurring at the time of a systemic insult or in close temporal association 
with a documented brain insult. Suggestions are made to define acute 
symptomatic seizures as those events occurring within 1 week of stroke, 
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traumatic brain injury, anoxic encephalopathy, or intracranial surgery; at 
first identification of subdural hematoma; at the presence of an active 
central nervous system (CNS) infection; or during an active phase of 
multiple sclerosis or other autoimmune diseases. In addition, a diagnosis of 
acute symptomatic seizure should be made in the presence of severe 
metabolic derangements (documented within 24 h by specific biochemical 
or hematologic abnormalities), drug or alcohol intoxication and 
withdrawal, or exposure to well-defined epileptogenic drugs 
          Acute symptomatic seizures were further grouped  into two broad 
categories: 1) acute symptomatic seizure caused by acute  neurological 
insult; and 2) acute symptomatic seizure  caused by acute  metabolic 
disorder.  
Some of the most common situations are listed 
Head injury 
     Seizures  occurring within 7 days of a traumatic brain injury. 
Cerebrovascular accident 
     Seizures  occurring within 7 days of any cerebrovascular accident. 
CNS infection 
     Seizures  occurring  in the course of active CNS infection. 
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CNS tumor 
     Seizures  occurring  as the presenting symptom of a CNS tumor. 
Post intracranial surgery 
     Seizures occurring in the immediate postoperative period of an 
intracranial neurosurgical intervention 
Toxic 
     Seizures occurring during the time of exposure to recreational drugs 
(e.g., cocaine), prescription drugs (e.g., aminophylline, imipramine), drug 
overdose, environmental exposure (carbon monoxide, lead, camphor, 
organophosphates), and alcohol (acute alcohol intoxication). 
Withdrawal 
     Seizures occurring in association with elimination of alcohol and 
drugs (e.g., barbiturates, benzodiazepines) .  
Metabolic 
     Seizures related to systemic disturbances, e.g., electrolyte 
imbalance, hypoglycemia,  uremia, cerebral anoxia, and eclampsia.  
Fever 
     Seizures occurring with fever in the absence of CNS infection in 
children. 
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Multiple causes 
Seizures occurring with several concomitant conditions. 
Undefined 
     Seizures occurring in the context of any acute not otherwise 
definable condition  
 Classification of Generalised and partial  seizures 12, 13  
I. Generalized onset 
A. Seizures with tonic and/or clonic manifestations 
     1. Tonic-clonic seizures 
     2. Clonic seizures 
     3. Tonic seizures 
B. Absences 
     1.Typical absences 
     2. Atypical absences 
     3. Myoclonic absences 
C. Myoclonic seizure types 
    1. Myoclonic seizures 
    2. Myoclonic astatic seizures 
    3. Eyelid myoclonia 
D. Epileptic spasms 
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E. Atonic seizures 
II. Focal onset (partial) 
A. Local 
1. Neocortical 
       a. Without local spread 
           i Focal clonic seizures 
          ii Focal myoclonic seizures 
          iii Inhibitory motor seizures 
          iv Focal sensory seizures with elementary symptoms 
          v Aphasic seizures 
     b. With local spread 
        i Jacksonian march seizures 
       ii Focal (asymmetrical) tonic seizures 
       iii Focal sensory seizures with experiential symptoms 
2. Hippocampal and parahippocampal 
    B. With ipsilateral propagation to: 
        1. Neocortical areas (includes hemiclonic seizures) 
        2. Limbic areas (includes gelastic seizures) 
  C. With contralateral spread to: 
      1. Neocortical areas (hyperkinetic seizures) 
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      2. Limbic areas (dyscognitive seizures without automatisms 
[psychomotor]) 
  D. Secondarily generalized 
    1. Tonic-clonic seizures 
    2. Absence seizures 
    3. Epileptic spasms (unverified) 
III. Neonatal seizures 
Status epilepticus 
     I. Epilepsia partialis continua (EPC) 
         A. As occurs with Rasmussen syndrome 
         B. As occurs with focal lesions 
         C. As a component of inborn errors of metabolism 
II. Supplementary motor area (SMA) status epilepticus 
III. Aura continua 
IV. Dyscognitive focal (psychomotor, complex partial) status epilepticus 
    A. Mesial temporal 
    B. Neocortical 
V. Tonic-clonic status epilepticus 
VI. Absence status epilepticus 
   A. Typical and atypical absence status epilepticus 
   B. Myoclonic absence status epilepticus 
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VII. Myoclonic status epilepticus 
VIII. Tonic status epilepticus 
IX. Subtle status epilepticus 
Localization-related epilepsies and syndromes 
1.1 Idiopathic 
         Benign childhood epilepsy with centrotemporal spikes 
         Childhood epilepsy with occipital paroxysms 
         Primary reading epilepsy 
1.2 Symptomatic 
     Chronic progressive epilepsia partialis continua of childhood 
(Kojewnikow  syndrome) 
    Syndromes characterized by seizures with specific modes of 
precipitation 
       Temporal lobe epilepsies 
       Frontal lobe epilepsies 
       Parietal lobe epilepsies 
       Occipital lobe epilepsies 
1.3 Cryptogenic 
2. Generalized epilepsies and syndromes 
    2.1 Idiopathic 
     Benign neonatal familial convulsions 
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    Benign neonatal convulsions 
    Benign myoclonic epilepsy in infancy 
    Childhood absence epilepsy 
    Juvenile absence epilepsy 
    Juvenile myoclonic epilepsy 
    Epilepsy with GTCS on awakening 
    Other generalized idiopathic epilepsies not defined above 
    Epilepsies with seizures precipitated by specific modes of activation 
2.2 Cryptogenic or symptomatic 
    West syndrome 
    Lennox-Gastaut syndrome 
    Epilepsy with myoclonic-astatic seizures 
    Epilepsy with myoclonic absences 
2.3 Symptomatic 
2.3.1 Nonspecific  etiology 
    Early myoclonic encephalopathy 
    Early infantile epileptic encephalopathy with suppression burst 
    Other symptomatic generalized epilepsies not defined above 
2.3.2 Specific syndromes 
   Epileptic seizures may complicate many disease states. Under this 
heading are included diseases in which seizures are a presenting or 
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predominant feature 
3. Epilepsies and syndromes undetermined whether focal or generalized 
3. I With both generalized and focal seizures 
     Neonatal seizures 
    Severe myoclonic epilepsy in infancy 
     Epilepsy with continuous spike-waves 
     Acquired epileptic aphasia (Landau-Kleffner  syndrome) 
    Other undetermined epilepsies not determined above 
3.2 Without unequivocal generalized or focal features. 
 All cases with generalized tonic clonic seizures in which clinical and EEG 
findings do not permit classification as clearly generalized or localization 
related, such as in many cases of sleep grand mal (GTCS) are considered 
not to have unequivocal generalized or focal features. 
4. Special syndromes 
4.1 Situation-related seizures  
     Febrile convulsions 
     Isolated seizures or isolated status epilepticus 
     seizures occurring only when there is an acute metabolic or toxic event 
due   
     to factors such as alcohol, drugs, eclampsia, nonketotic  hyperglycemia 
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Classification of seizures according to risk factors  
Epileptic seizures and the epilepsies may be a manifestation of many 
cerebral or systemic diseases. The first step in categorization of seizures 
should be based on the presence or absence of a presumed acute 
precipitating insult, which will permit distinction into provoked and 
unprovoked seizures. Provoked seizures are therefore equivalent to acute 
symptomatic or situation-related seizures. Single or recurrent unprovoked 
seizures may belong to two possible categories: symptomatic seizures or 
epilepsies (of presumed remote cause) and seizures or epilepsy of 
unknown causes. Identification of the cause may depend on the degree of 
investigation, which also depends on availability of ancillary tests. 
3.1 Symptomatic seizures or epilepsies – consequence of a known cerebral  
dysfunction 
3.1.1 Acute symptomatic – seizures are in close temporal association 
(within 7 days) with an acute systemic, metabolic or toxic insult and with 
acute CNS insult (infection, stroke, cranial trauma, intracerebral  
hemorrhage, acute alcohol  intoxication or withdrawal). 
3.1.2. Unprovoked seizures 
Seizures may occur in relation to a well demonstrated antecedent 
condition, substantially increasing the risk for epileptic seizures. Two 
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major subgroups may be categorized: Remote symptomatic unprovoked 
seizures owing to conditions resulting in a static encephalopathy. Such 
cases are individuals with epilepsy subsequent to an insult to the CNS, 
such as infection, cerebral trauma, or cerebrovascular disease, which are 
generally presumed to result in a static lesion. Second subgroup is due to 
symptomatic unprovoked seizures owing to progressive CNS disorders 
Evaluation of a first seizure 8,14,15 
History of the event  
A description of the circumstances surrounding a paroxysmal event can 
provide important diagnostic clues. A witnessed, 90-second episode that 
involved loss of consciousness, stiffening, and jerking of the extremities 
followed by muscle soreness, headache, and the need to sleep for several 
hours afterwards strongly suggests a tonic-clonic seizure 
KEY  ELEMENTS  IN  HISTORY 
Before the event  
Unusual stress (eg, severe emotional trauma) 
Sleep deprivation, Recent illness 
Unusual stimuli (eg, flickering lights) 
Use of medications and drugs 
Activity immediately before event (e.g., change in posture, exercise)  
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During the event 
Symptoms at onset (e.g., aura) 
Temporal mode of onset: gradual versus sudden 
Duration: brief (ictal  phase <5 min) versus prolonged 
Stereotypy: duration and features of episodes nearly identical versus  
changing 
Time of day: related to sleep or  occurring  on awakening 
Ability to talk and respond appropriately 
Ability to comprehend 
Ability to recall events during the seizure 
Abnormal movements of the eyes, mouth, face, head, arms, and legs 
Bowel or bladder incontinence 
Bodily injury  
After the event 
Confusion 
Lethargy 
Abnormal speech 
Focal weakness or sensory loss (i.e., Todd's paralysis) 
Headache, muscle soreness, or physical injury 
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Past medical history      
A review of the events leading up to the seizure may reveal factors 
that suggest it was provoked. Causes of provoked seizures include alcohol 
withdrawal, substance abuse, hypoxia, fever, electrolyte imbalance, 
hypoglycemia, and sleep deprivation.  
Drug history 
Theophylline, meperidine hydrochloride , isoniazid , antipsychotic 
drugs (especially clozapine and phenothiazines), radiocontrast dyes, 
alkylating agents, and ß-lactam antibiotics, quinolones are among the most 
commonly implicated medications in seizure.  
Physical examination  
A thorough physical examination can help uncover possible causes 
of a seizure. Findings may include evidence of trauma, infection, 
malignancy, congenital anomalies, and prior neurologic events (e.g., focal 
weakness, spasticity suggesting previous stroke).  
During an emergency department evaluation of a patient 
immediately after a seizure, vital signs should be measured and a general 
medical examination performed. Guidelines for physical examination are 
as follows:  
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• Examine the patient for injuries from the seizure or fall.  
• Check oxygen saturation and auscultate the chest for possible 
aspiration.  
• Measure heart rhythm and rate, blood pressure, and orthostatic 
changes for assessment of syncope.  
• Auscultate for carotid murmurs or carotid bruits and sources of 
embolic stroke.  
• Check for rapid pulses, which are often present after seizure and 
may help in evaluation of psychogenic seizures.  
An electrocardiogram should be obtained to identify cardiac rhythm, 
detect possible ischemia, and measure the QT interval. Prolonged QT 
syndrome often presents with simple or convulsive syncope. 
Electrocardiography and 24-hour ambulatory continuous 
electrocardiographic (Holter) monitoring can help identify cardiac 
arrhythmias. The possibility of a recent myocardial infarction should be 
considered, particularly in elderly patients, in whom myocardial infarction 
may occur from the stress of a seizure.  
Neurologic examination  
The purpose of the neurologic examination is to identify focal or 
diffuse cerebral dysfunction. This information is particularly helpful in 
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localization-related epilepsy. The presence of various features offers clues 
to the focus of a seizure. For example, aphasia suggests a left frontal, 
temporal, or parietal onset. Right or left hemiparesis suggests foci from the 
contralateral motor cortex.  
In initial evaluation of a seizure, patients should be observed for 
fluency of language, facial asymmetry, gaze preferences, and pupillary 
asymmetry. The last presents in patients who have herniation from brain 
swelling caused by parenchymal or epidural bleeding and in those who 
have a rapidly growing brain tumor. The presence of pronator drift may 
indicate subtle weakness not detected by strength testing. Sensory deficits 
suggest parietal lobe dysfunction. An extensor plantar response may be 
noted for some time after a seizure and is not necessarily a pathologic 
finding.  
Diagnostic testing  
Laboratory workup is an essential part of evaluation of seizure. 
Measurement of glucose, calcium, magnesium, thyroid hormone, and liver 
enzyme levels, as well as toxicology screening (including blood alcohol 
levels), may reveal common medical causes of seizures. A complete blood 
cell count may suggest infection, anemia, or sickle cell disease.  
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In patients suspected to have had an infection or a fever or to have 
exhibited abnormal behavior just before the event, lumbar puncture should 
be performed after assessment of the possible risks of the procedure (e.g., 
coagulopathy, mass lesion). Patients who are immune compromised 
because of corticosteroid use, recent transplantation, or HIV infection 
should undergo cerebrospinal fluid evaluation to detect possible fungal, 
bacterial, or viral infection. In patients with a systemic malignant 
condition, cytologic evaluation of cerebrospinal fluid can identify 
meningeal carcinoma.  
Electroencephalogram: 
• EEG should be performed within 24 hours of the seizure because it 
is significantly more sensitive when obtained during that period 16. If 
the routine EEG findings are normal, a sleep-deprived EEG should 
be performed. 
• Standard EEG detects epileptiform discharges in 29% of patients. 
Standard EEG combined with sleep-deprived EEG shows 
epileptiform discharges in 48% of patients 17. 
• Schreiner and Pohlmann18 studied the value of an EEG taken within 
48 hours of the first seizure in an adult. They found that 38.0% of 
patients without seizure recurrence had normal EEGs, while only 
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10.2% of patients with seizure recurrence had normal EEGs. Focal 
epileptiform activities were found significantly more frequently 
(26.5% vs. 13.0%) in patients with seizure recurrence than in 
patients without seizure recurrence. 
Limitation  of  EEG:  
An estimated 0.4% of adults and 2.8% of children who have never 
had a seizure may have interictal  epileptiform  discharges. Furthermore, a 
normal EEG does not refute the diagnosis of epilepsy. The initial EEG 
reveals epileptiform activity in only 40% of the patients with probable 
epilepsy. 
Imaging studies 
The role of imaging studies depends on the stage of evaluation. 
Immediately after a seizure, computed tomography can detect the presence 
of bleeding or gross structural lesions. However, magnetic resonance 
imaging is the study of choice because it is more sensitive and specific for 
evaluating structural lesions and brain parenchyma. Particular attention 
should be directed to the hippocampus for evaluation of lesions (e.g., 
mesial temporal sclerosis) and to the cortical architecture for detection of 
abnormalities (e.g., dysplasia).  
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Incidence of Acute Symptomatic Seizures 
Overall Incidence 
Only two studies provide detailed information regarding the 
incidence of acute symptomatic seizures 19,20,21 The incidence of seizures 
occurring at the time of systemic metabolic insults or temporally 
associated with an insult to the central nervous system (CNS) was 
determined for the residents of Rochester, Minnesota. The age-adjusted  
incidence  rates for 1955 to 1984, the period of most complete case 
ascertainment, was 39 per 100,000 person-years (U.S. 1970 population). 
This rate is somewhat higher than that reported in Gironde, Bordeaux, 
France 21 which was 29 per 100,000 person-years.  
Gender 
  From  the conditions associated with acute symptomatic seizures, 
men seem to be at higher risk than women. In both the French study21 and 
the U.S. study19, the age-adjusted incidence in men was considerably 
higher than that in women.  
Age 
The age-specific incidence of acute asymptomatic seizures in the 
U.S. study19 was by far the highest during the first year of life . This is 
attributable to the high incidence of acute symptomatic seizures associated 
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with metabolic, infectious, and encephalopathic causes during the neonatal 
period. Incidence declined in childhood and the early adult years and 
reached a nadir of 15 per 100,000 person-years among those 25 to 34 years 
of age. After 35 years of age, the incidence increased progressively, and 
reached 123 per 100,000 among those older than 75 years of age. 
Cerebrovascular disease accounted for about half of all acute symptomatic 
seizures in persons older than 65 years of age. As mentioned previously, 
age-adjusted incidence is considerably higher in men than women. The sex 
difference was greatest at the extremes of age. Between the ages of 15 and 
44, there were few differences among all causes of acute symptomatic 
seizures. Seizures associated with eclampsia in women of childbearing age 
offset a lower incidence of seizures among women associated with other 
causes. The age-specific incidence rates of acute symptomatic seizures in 
the French21 and U.S.19 studies were similar in middle-aged men, but the 
U.S. rates were higher in children younger than 15 years of age and in the 
elderly.  
Causes of Acute Symptomatic Seizures 
The major causes of acute symptomatic seizures in both the French 
and U.S. studies were traumatic brain injury, cerebrovascular disease, drug 
withdrawal, and CNS infection. The underlying causes of the seizures are 
reflected in patterns of age, sex, and time period. Although the overall 
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proportional distribution by cause was similar in the United States and 
France, no age or etiology specific data are available for the latter study. 
Acute Symptomatic Seizures Associated with Primary Brain Insults 
Central Nervous System Infection 
Acute symptomatic seizures in infections of the central nervous 
system are those occurring during the acute phase of infection. About 5% 
of people with CNS infection can be expected to experience an acute 
symptomatic seizure.22 Infections of the CNS accounted for about 15% of 
all acute symptomatic seizures in both  Bordeaux, France,21 and Rochester, 
Minnesota.19 In the latter study, the age-specific trends of acute 
symptomatic seizures associated with CNS infection followed the pattern 
of incidence of CNS infection.23 The highest incidence was during the first 
year of life and in children younger than 15 years of age; the incidence was 
lower in adults. Overall, the age-adjusted incidence in men is twice that in 
women. Seizures are second only to headache as a presenting symptom of 
neurocysticercosis. It is assumed that most of these seizures are acute 
symptomatic and are associated with the response to the acute 
inflammatory response associated with transitional cyst degeneration.24 
Unlike most time delimited insults associated with acute symptomatic 
seizures, the inflammatory response may last from weeks to months, thus 
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requiring a modification of some of the usual concepts of acute 
symptomatic seizures.25 
Brain Trauma 
Seizures occurring within the first week of a traumatic brain injury 
are generally assumed to be acute symptomatic. Seizures occurring after 
that time are generally considered late or unprovoked, although it would 
certainly be more appropriate to include the concept of stabilization in 
such definitions. In civilian studies of traumatic brain injuries, about 6% of 
all cases are associated with acute symptomatic seizures.26,27 The 
frequency of early seizures increases with severity of injury and probably 
represents a surrogate for severity. Acute symptomatic seizures associated 
with head trauma accounted for about 15% of all acute symptomatic 
seizures occurring in Rochester19 and only about 5% of all cases in 
Bordeaux21. Traumatic acute symptomatic seizures in Rochester were more 
common in men (age-adjusted rate, 8.6) than in women (age-adjusted rate, 
4.8) at all ages. The age specific incidence of head trauma is trimodal.28,29 
Given similar levels of severity of injury, children are at higher risk  for  
acute symptomatic seizures  than  adults.26 
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Cerebrovascular Disease 
Following the example of brain injury, acute symptomatic seizures 
associated with cerebrovascular disease are generally limited to seizures 
occurring within 1 week of the acute ictus. Between 5% and 10% of 
individuals with a cerebrovascular insult experience a seizure at the time of 
stroke.30,31,32 The frequency varies with the nature of the insult and is 
probably highest in those with intracerebral haemorrhage. In Bordeaux, 
cerebrovascular disease accounted for about one third of all cases of acute 
symptomatic seizures, compared with only 15% of all cases in Rochester. 
Paralleling the incidence of cerebrovascular disease,33 acute symptomatic 
seizures associated with stroke are rare in persons younger than 55 years of 
age; the incidence rises rapidly with increasing age, reaching 54.6 per 
100,000 among persons older than 75 years of age. The age-adjusted 
incidence of acute symptomatic seizures is higher in men than in women 
(9.4 vs. 4.7 per 100,000 cases).33 The sex-specific difference is particularly 
dramatic in those 65 to 74 years of age: 55.1 per 100,000 in men versus 
15.5 per 100,000 in women. In Rochester, the age-specific incidence of 
acute symptomatic seizures associated with cerebrovascular disease was 
stable from 1945 through 1974 but fell in the final decade along with the 
incidence of stroke.33 The age-adjusted incidence fell through the years 
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from 8.6 in the decade 1955 to 1964 to 6.5 in the decade 1964 to 1974 to 
5.1 in the decade 1975 to 1984. 
Brain Tumor 
There is debate about how to classify seizures associated with brain 
tumors. A high proportion of individuals with brain tumors may 
experience acute symptomatic seizures.34 In Rochester, acute symptomatic 
seizures associated with primary or secondary brain tumors occurred at all 
ages but were rare in persons younger than 45 years of age. The age-
specific incidence rates in persons older than 45 years of age were constant 
at 6 to 8 per 100,000 person-years. Unlike most other acute symptomatic 
seizures, seizures associated with neoplasm were equally common in men 
and women. 
Acute Symptomatic Seizures Associated with Systemic Disturbances 
Seizures occurring in association with systemic insults are easy to 
identify, although strict operational definitions are elusive. The severity of 
a systemic insult or the timing of the seizures from the start of the insult is 
seldom specified.35 Nonetheless, this category accounts for a substantial 
proportion of all acute symptomatic seizures. 
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Eclampsia 
In the Rochester studies36, 15 women had seizures attributed to 
eclampsia during a 50-year period; this accounted for about 3% of acute 
symptomatic seizures in women, an incidence of 2.8 per 100,000 women 
ages 15 to 44 years.. In Houston, Texas, the incidence of eclampsia in two 
inner-city hospitals from 1982 to 1992 was 0.7 per 1,000 deliveries, a 
frequency similar to that in Rochester, Minnesota, in the 1940s.  
Toxic Insults 
Seizures may occur in association with a variety of toxic insults 
(e.g., carbon monoxide poisoning or acetylsalicylic acid overdose). Toxic 
insults accounted for about 5% of all acute symptomatic seizures in 
Rochester, but only a small proportion of cases in Bordeaux. This may be a 
consequence of differences between these two studies in inclusion criteria 
for this category. In Rochester, the overall incidence of acute symptomatic 
seizures associated with toxic insults was 2.2 per 100,000 cases, with the 
highest incidence in the elderly (older than 75 years of age). 
Drug Withdrawal 
Most drug withdrawal seizures are associated with abuse of ethanol 
and, less frequently, barbiturates or other substances. This category of 
acute symptomatic seizures accounted for about 15% of cases in 
31 
 
Rochester19 and about one third of cases in Bordeaux.21 Incidence for this 
group of acute symptomatic seizures peaked in the 35- to 54-year-old age 
group. Withdrawal seizures were the primary cause of acute symptomatic 
seizures for those 25 to 55 years of age. The incidence of seizures 
attributed to this cause progressively increased during the study period.  
Metabolic Insults 
Systemic metabolic illness accounted for about 10% of all acute 
symptomatic seizures in Rochester19 and about 15% of cases in 
Bordeaux.21 In Rochester, the incidence of acute symptomatic seizures 
attributed to metabolic insults was highest during the first year of life. This 
was largely caused by hypocalcemia or hypoglycemia in newborns. These 
cases were identified primarily before 1960; they are virtually nonexistent 
at the present time in this community, although it is conceivable that they 
continue to account for a substantial proportion of newborn cases in less 
medically sophisticated areas. Seizures associated with metabolic 
disturbances were rare between the second week of life and 55 years of 
age. There was a slight rise in incidence after this age. 
Prognosis of Acute Symptomatic Seizures 
In general, acute symptomatic seizures are a reflection of disease 
severity and, as such, are associated with a relatively high mortality 
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rate.37,38,39 However, prognosis obviously varies with the underlying 
condition. No studies address the influence of acute symptomatic seizures 
on risk for mortality within given conditions, so it is impossible to assess 
the contribution of seizures per se on mortality. In survivors of neurologic 
insults, those with acute symptomatic seizures seem to be consistently at 
increased risk for subsequent epilepsy compared with those without acute 
symptomatic seizures.40 This is probably not related to a kindling 
phenomenon but rather to the increased severity of initial insult in those 
with acute symptomatic seizures. Acute symptomatic seizures associated 
with metabolic insults are not associated with a similar increase in risk for 
subsequent epilepsy. None of the cases of eclampsia in the Rochester 
cohort had subsequent seizures. There has been no systemic study of the 
risk for epilepsy in people with other metabolic conditions 
TREATMENT  
        The treatment 41of seizures of all types can be divided into the use of 
antiepileptic drugs, the surgical excision of epileptic foci and other surgical 
measures, the removal of causative and precipitating factors, and the 
regulation of physical and mental activity .Choices of antiepileptic drugs 
depends on  type of  seizure  and patient characteristics .Preferably start a 
conventional or first line AED like phenytoin , phenobarbitone, 
carbamazepine, oxcarbamazepine ,or valproate .Newer AED’s are 
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lamotrigine ,leviteracetam, topiramate, zonisamide,  gabapentin,  tiagabine  
and  felbamate. 
 Treatment of the underlying  condition along with AED is very 
important in patients with acute symptomatic seizures .Seizures due to 
metabolic and withdrawal states, treatment with anticonvulsants is usually 
not necessary as long as the underlying disturbance is rectified. 
Antiepileptic drug therapy should be started in any patient with recurrent 
seizures of  unknown etiology or a known cause that cannot be reversed. 
Initiating  therapy in a patient with a single seizure is controversial .  
Patients  with structural  brain lesions  like tuberculoma, NCC or single 
enhancing lesion, brain tumor, vascular malformation, or brain abscess 
need AED  until resolution of  lesion  and maintain  on an  antiepileptic 
medication for 6 to 12 months42, and an attempt is made to withdraw  
medications only if the patient has been completely seizure-free(1). If 
seizures are  refractory to medication, the patient may benefit from surgical 
removal of the  epileptic brain region. Single  seizure after stroke may not 
be treated and if  there  is high risk for recurrence AED can  be  given43,44,45 
. Level A evidence is present only for lamotrigine and gabapentin as first-
line antiepileptic drugs for treatment of partial-onset seizure in the elderly 
46. Slow release formulations of carbamazepine (400 mg) have also been 
found to be equally effective.47 For patients  with CVT  use of  AED is 
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recommended for one year.42Patients   with brain  tumors AED should be  
given before and after surgery . Patients  with  uremic  seizures safer 
AED‘s  are phenobarbitone, lamotrigine,valproate and phenytoin .42 
             Patients  with  tuberculoma  or TB meningitis  should be treated 
with ATT. 6month course is  acceptable but should be treated 9-12 months 
in patients who have an inadequate resolution or positive culture during 
treatment . Steroids should be given to prevent complications .  For brain 
abscess high dose parenteral antibiotics and surgical drainage are advised . 
Neurocysticercosis  is treated with albendazole 15mg/kg /d in 2 doses for 8 
days or praziquantel 50mg/kg/d for 15 days 48. For patients with CVT 
anticoagulants initially intravenous followed by oral and antibiotics if it is 
septic thrombophlebitis  are employed . Patients  with tumor  have to be  
treated surgically followed by radiotherapy or chemotherapy .           
         Patients with status epilepticus 49should be treated promptly  as the 
condition is associated with high mortality. Quick assessment of  
cardiorespiratory function  and  airway   and  insert   large-bore 
intravenous line and draw blood  for glucose, blood urea nitrogen, 
electrolytes, and a metabolic and drug screen. A normal saline infusion is 
begun and a bolus of  glucose is given (with thiamine if malnutrition and 
alcoholism are factors). Diazepam is given intravenously at a rate of about 
2 mg/min until the seizures stop or a total of 20 mg has been given or 
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lorazepam, 0.1 mg/kg given by   intravenous   push at a rate not to exceed 
2 mg/min . A loading dose  20 mg/kg of phenytoin is administered  by iv at 
a rate of  less than 50 mg/min or fosphenytoin at  150 mg/min. If the 
seizure is not controlled repeat phenytoin 7-10mg/kg.Consider sodium 
valproate 25mg/kg or phenobarbitone 20mg/kg  infusion if the seizure still  
continues. Admit in ICU and give iv anaesthesia with midazolam or 
propofol as next step .Once the seizure is controlled continue maintenance 
AED. 
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AIM AND OBJECTIVES 
To analyse the demography, etiological profile, the pattern of 
seizures, the clinical findings, usefulness of various investigations, and the 
incidence of potentially curable causes for the patients presenting with 
acute symptomatic seizures  in the age group of 60 years and above. 
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MATERIALS AND METHODS 
THE STUDY GROUP  
      The study was conducted on inpatients and out patients of Institute of 
Neurology, Department of Internal Medicine and Intensive medical care 
unit of Rajiv Gandhi Govt General Hospital Chennai. Approval from the 
hospital ethical committee was obtained. The study was observational, 
cross sectional study in nature designed to analyse the patients in  age 
group of 60 years  and above , who presented with acute symptomatic 
seizures. The sample size was 100 and the study period was from January 
2009 to March 2011. 
INCLUSION CRITERIA: 
1. Patients  admitted with first episode of acute symptomatic seizures . 
2. Age  60 years and above. 
3. Patients admitted for other medical conditions, who developed acute 
symptomatic seizures during the hospital stay. 
EXCLUSION CRITERIA: 
1. Patients with previous history of seizures. 
2. Idiopathic seizures. 
3. History of head injury 
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Clinical data was collected from patients and witnesses in a 
systematic manner and added to a database, which included a checklist of 
seizure antecedents and the symptoms associated with seizure. The first 
task was to ascertain if  at all, the presenting complaint is a seizure. In a 
few instances, even when the presenting history was ambiguous seizure 
recurrences were witnessed for confirmation. The clinical diagnosis on the 
seizure type, whether partial or generalized was made.  
In depth probes in the history for provocation factors and  features 
suggesting organicity were attempted. Significant past medical history if 
any were noted. A thorough clinical examination was performed at the 
time of admission and relevant findings recorded. A routine metabolic 
screening, which included blood sugar, urea, serum creatinine, electrolytes 
and liver function tests (if indicated), were done at the time of admission.  
          Lumbar puncture and CSF analysis was done if infective etiologies 
were suspected. Earliest possible EEG was attempted and was performed 
using 32 channel digital EEG recorder.                                                                
          CT brain plain  in all patients and contrast studies when necessary 
were done in all patients in the study group. MRI brain was done when 
indicated. Limitations were encountered in affordability of patients for 
MRI scanning. Early EEG (within 24hours of onset of seizures) could not 
be performed due to delay in referral of the patients to this institution and 
because of the time taken for stabilizing patients.  
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RESULTS AND ANALYSIS 
Acute symptomatic seizures in the age group of 60 years and above 
were studied. The result of the study was shown below.  
EPIDEMIOLOGY  
Number of cases of Acute Symptomatic seizures studied in 60 years 
and above was 100. 
Table 1- Age Distribution 
 Cases 
No Percentage 
60-70 52 52% 
71-80 32 32% 
>80 16 16% 
 
In the present study, patients age ranges from 60-87 years.  Most of 
the patients were in the age group  of 60-70 years, which was about 52% of 
the total number of cases. 
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Table 2-Sex Distribution 
Sex 
Cases 
No Percentage 
Male  60 60% 
Female  40 40% 
Out of 100 cases in this study, 60% were male and 40% were females.  
Table 3- Type of Seizures 
Type of Seizures 
Cases 
No Percentage 
Partial  61 61 
Generalized  39 39 
 
Out of 100 cases in this study 61% had partial seizures, 39% had 
generalized seizures. Simple partial seizures were seen in 41% of cases, 
simple partial seizures with secondary generalization, were seen in 20% of 
cases. Status epilepticus was seen in 27% of cases. 
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Table 4- Associated Non Convulsive Symptoms 
Symptoms No 
Limb weakness  62 
Cranial nerve deficit   30 
Speech disturbance  14 
Fever  15 
Headache  15 
Vomiting  14 
 
            62% of cases with acute symptomatic seizures with cerebrovascular 
disease presented with limb weakness, cranial nerve deficit were seen in 
30% of cases, speech disturbances were seen in 14% of cases, patients with 
central nervous system  infections and cerebral venous thrombosis had 
headache and vomiting. 15% of patients had fever at the onset of illness. 
Headache was present in 15 patients of which 7 of the patient had 
meningitis.  
 
42 
 
Table-5 Profile of Significant Past Medical Illness 
Past medical illness No 
Diabetes Mellitus  27 
Systemic Hypertension  22 
Chronic Kidney Disease   3 
Pulmonary Tuberculosis  5 
Coronary Artery Disease  7 
Neoplasm  4 
 
Out of 100 patients, 27 patient had diabetes mellitus, 22 patient had 
systemic hypertension, 6 patients had both diabetes mellitus and systemic 
hypertension, 5 patients had past history of pulmonary tuberculosis, 7 
patients had coronary artery disease, 3 patients had chronic kidney disease, 
4 patients had history of carcinoma, 2 of them had bronchogenic 
carcinoma, 1 had renal carcinoma and 1 had bladder carcinoma.    
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Table-6- Profile of Neurological Signs at Admission 
 
Neurological signs No 
Altered  sensorium   21 
Cranial nerve deficit  16 
Motor system deficit  62 
Sensory system deficit  6 
Signs of meningeal irritation   8 
 
Altered sensorium level was seen in 21 patients in our study  which 
ranges from coma to drowsiness, cranial nerve deficit were seen in 16 
patients. Most of the patients had facial nerve involvement, sensory system 
deficit were seen in 6 patients, signs of meningeal irritation were been in 8 
patients.   
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Table-7- Etiology Profile 
 
Causes No Percentage 
Cerebrovascular disease  62 62 
Central Nervous system infections  15 15 
Metabolic  causes 10 10 
Alcohol withdrawal seizures   5 5 
Toxins  4 4 
Neoplasm 4 4 
 
Out of 100 patients with acute symptomatic seizures in the study 
group, cerebrovascular disease were seen in 62 patients which is the most 
common cause. Central nervous system infections contributed to 15% of 
patients, metabolic causes were seen in 10 patients, alcohol withdrawal 
seizures were seen in 5 patients. Toxins and neoplasm induced seizures 
were seen in 4 patients each.   
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Table 8- Etiology and Age Distribution 
Causes 
Age Group 
60-70 71-80 >80 
Cerebrovascular disease  29 20 13 
Central Nervous system infections 7 6 2 
Metabolic 6 3 1 
Alcohol withdrawal seizures   3 1 1 
Toxins  2 1 1 
Neoplasm  4 - - 
 
Out of 100 patients in this study group, 51patients fall in the age 
group between 60-70 years. 31 patients fall in the age group between 71-
80 years and 18 patients in the age group 80 and above. Most of the causes 
which contributes to seizures in this study occurred in the age group 
between 60 -70 years of age. 
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Table-9 -Etiology and Sex Distribution 
Causes 
Sex 
Male Female 
Cerebrovascular disease  32 30 
Central Nervous system infections 9 6 
Metabolic 6 4 
Alcohol withdrawal seizures   5 - 
Toxins  3 1 
Neoplasm  4 - 
 
In this study, most of the patients were male, 59 of patients were 
seen in male and 41 patients were seen in female sex group and all causes 
of seizures were commonly observed in male gender. 
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Table10 -Etiology Profile of Cerebrovascular Disease 
 
Type Number 
Ischemic Cerebrovascular disease  39 
Intracerebral Haemorrhage  19 
Cerebral Venous thrombosis  4 
 
Cerebrovascular disease was the most common cause of acute 
symptomatic seizures in this study, out of  62% cases with cerebrovascular 
disease, ischemic cerebrovascular disease, were seen in 39% of patients, 
Intra cerebral haemorrhage were seen in 19% of patients and cerebral 
venous thrombosis were seen in 4% of patients.  
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Table 11 -Etiology Profile of Central Nervous System Infection 
 
Type Number 
Meningitis   8 
Encephalitis  4 
Tuberculoma 2 
Brain Abscess  1 
 
Central nervous system infections was the second most common 
cause of seizures in this study, which is about 15%, meningitis were seen 
in 8% of patients and encephalitis  were seen in 4% of patients.  
      Metabolic causes were observed in 10% of cases. Hypoglycemia 
was the commonest metabolic cause which contributes to 5% of total 
cases. Other causes being uremia in  3% and hyperglycemia  in 2% of total 
cases. Brain secondaries were seen in 4% of cases . Bronchogenic 
carcinoma were seen in 2 cases as primary, renal and Bladder carcinoma 
was seen in 1 each.  
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Table 12-Etiology Profile of Metabolic Causes 
Causes Number Percentage 
Hypoglycemia 5 5 
Hyperglycemia  2 2 
Uremia 3 3 
 
Toxins induced causes was seen in 4 patients.organophosphorous 
poisoning was seen in 3 patients and permethrin poisoning was observed in 
1 patients.  
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Table 13- Etiology Profile of Patient with Status Epilepticus 
Causes Number 
Cerebrovascular Disease  15 
CNS Infection  6 
Alcohol withdrawal  1 
Metabolic  3 
Toxins  2 
 
Status epilepticus  was seen in 27 patients in the study group. 
Cerebrovascular diseases was the most common cause for status 
epilepticus in this study. Status epilepticus occurred in 15 patients with 
cerebrovascular disease,central nervous infection was the next most 
common cause for status epileptiucs  in 6 patients. 
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Table-14- Profile of EEG in the Study Group 
  
EEG Findings Number Percentage 
Normal  73 73 
Focal Slowing  14 14 
Diffuse Slowing  9 9 
Epileptiform discharge  4 6 
 
EEG was normal in 73 patients. Out of 23 patients with abnormal 
EEG, most common abnormality was focal slowing in 14 patients. Diffuse 
slowing was observed in 9 patients, only 4 patients showed epileptiform 
discharges. 
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Table – 15: Profile of EEG in cerebrovascular Disease 
EEG Findings Number 
Normal 45 
Focal slowing 14 
Epileptiform discharge 3 
 
Out of 62 patients with cerebrovacscular disease. EEG was normal 
in 45 patients. Abnormal EEG was seen in 17 patients. 
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Table 16-CT brain abnormality in the study group 
CT Brain finding Number 
Ischemic Infarction 35 
Parenchymal haemorrhage 19 
Cortical atrophy 20 
Haemorrhagic infarction 2 
Tuberculoma 1 
Meningeal enhancement 3 
Neoplasm 4 
 
CT scan brain was abnormal in 61 patients, Ischemic infarction was 
seen in 35 patients which was the most common abnormality. Parenchymal 
haemorrhage was seen in 19 patients. Cortical atrophy was seen in 20 
patients, which was found in combination with other abnormal CT 
findings. Haemorrhagic infarction was seen only in 2 patients. Ring 
enhancing tuberculoma lesion was seen in only 1 patient. 
54 
 
 
Table17-New Lesions uncovered in MRI brain 
     MRI Brain finding Number 
Ischemic Infraction 4 
Encephalitis 4 
Cerebral venous thrombosis 2 
Tuberculoma 2 
Cerebral abscess 1 
 
MRI brain was done in 75 cases. MRI was useful in uncovering, 
lesions which were missed  in CT brain in 13 patients. 4 patients with 
ischemic infarction who had normal CT brain findings, showed 
abnormality in MRI brain. Similarly 4 patients with encephalitis  showed 
abnormality in MRI brain. 
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DISCUSSION 
Rajiv Gandhi Government General Hospital, Chennai is the tertiary 
referral hospital and is the premier institute in the state of Tamil Nadu. 
Various cases have been referred from Government sector hospitals like 
primary health centres, Government General Hospitals, District head 
quarters hospitals and many private hospitals, not only from nearby 
Chennai but also from nearby districts in Tamil Nadu. Study on acute 
symptomatic seizures in the elderly patients was conducted from the period 
of January 2009 to March 2011, which included 100 patients. 
Epidemiology 
Analysing the age group in this study, the maximum incidence of 
acute symptomatic seizures occurred in the age groups of 60-70 years. This 
was about 52% in our study. In the study conducted by Ruggers et al50 on 
retrospective study of seizures in the elderly maximum incidence was in 
the age group of 60-70 years, which was about 44%. In another study 
conducted by Annergers et al19 on incidence of acute symptomatic seizures 
in the Rochester, the maximum incidence of 45% was in the age group of 
60-70 years. 
The study group comprised of 60% males and 40% females. Most 
authors report small to moderate preponderance of men in their studies of 
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acute symptomatic seizures in the elderly individuals. In the study 
conducted by Hauser et al19, the incidence of acute symptomatic seizures 
was 53% in males and 47% females. 
Table18-Comparison of sex distribution with other study 
Sex Our study % Hauser et al % 
Male 60% 53% 
Female 40% 47% 
 
Etiology 
Most common cause of seizures in our study was cerebrovascular 
disease, followed by central nervous system infections and metabolic 
causes. Cerebrovascular disease contributed to 62% in our study. Central 
nervous system infection contributed to 15% and metabolic causes 
contributed to 10%. Alcohol withdrawal seizures, toxins and neoplasm 
contributed to remaining 13% of cases. 
In the study conducted by Hauser et al19on acute symptomatic 
seizures,  cerebrovascular disease contributed to 57% ,  metabolic causes 
contributed to 11%, central nervous system infection in 3%,  toxin induced 
causes in 9%, Alcohol withdrawal seizures in 8% and  neoplasm in 12% of 
cases. 
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       In another study conducted by Alana Holt-Seitz et al51 on seizures in 
the elderly, etiology and prognosis, cerebrovascular disease contributed to 
46% of cases, metabolic causes contributed to 20%,central nervous system 
infections in 12% of cases, neoplasm in 17% of cases and alcohol 
withdrawl seizures in 5% of cases. 
Table19-Comparison of etiology profile with other studies 
 Hauser et al% Alana Holt 
etal % 
Our 
study% 
Cerebrovascular disease 57 46 62 
Central nervous system 
infections 
3 12 15 
Metabolic causes 11 20 10 
Alcohol withdrawl seizures 8 5 5 
Toxins 9 – 4 
Neoplasm 12 17 4 
 
Cerebrovascular disease was the most common cause for seizures in 
our study, which was seen in 62% of cases, when compared with various 
other studies, cerebrovascular disease was the most common cause  for 
acute symptomatic seizures in the elderly, similar to our study. It was 57% 
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in the study conducted by Hauser et al19, 46% in the study conducted by 
Alana Holt19, 52% in the study conducted by Ang Rt et al52, 44% in the 
study conducted by Wood Cock53, 73% in the Fine et al 54 and 57% in the 
study conducted by Gupta et al55. 
Table 20-Comparison of cerebrovascular disease as etiology  
with other studies 
Study Percentage 
Hauser et al 57 
Alana Holt et al 46 
Ang RT et al 41 
Wood cock et al 44 
Fine et al 73 
Gupta et al 40 
Our Study 62 
 
As observed in various other studies, cerebrovascular disease was 
the most common cause for seizures. Of the 62 cases of cerebrovascular 
disease, 63% of cases were due to Ischemic cerebrovascular disease, 31% 
of cases were due to intracerebral haemorrhage and 6% of cases were due 
to cerebral venous thrombosis.  
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In the study conducted by Daniel et al56 on prevalance and predictors 
of the early seizures and status epilepticus after first stroke, Ischemic 
infarction contributed to 60% of cases, intracerebral haemorrhage to 30% 
of cases and subarachnoid haemorrhage in 10% of cases. Thus ischemic 
infarction was the most common etiology, similar to our study. 
Table 21-Comparison of cerebrovascular disease profile  
with other studies 
Cerebrovascular Disease Daniel et al Our study 
Ischemic infarction 60 63 
Intracerebral haemorrhage 30 31 
Subarachnoid haemorrhage 10 – 
Cerebral venous thrombosis – 6 
 
Central nervous system infections, contributed to 15% of etiology of 
seizures in our study, meningitis is the most common cause among 
infections, which contributed to 8% of total 15% of cases. In the study 
conducted by Alana Holt etal51on seizures in elderly, incidence of central 
nervous system infection was 15% and in other study conducted by Hauser 
et al19, the incidence was 3% of total cases. 
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Table 22-Comparison of central nervous system infection as Etiology 
with other studies 
Study Percentage 
Alana Holt et al 15 
Hauser et al 2 
Our study 15 
 
Metabolic causes contributed to 10% of cases as etiology in our 
study. Among the 10% of cases, hypoglycemia was the common cause, 
which was seen in 5% of cases, uremia in 3% of cases and hyperglycemia 
in 2% of cases. They were the most readily treatable cause for acute 
symptomatic seizures, especially those patients detected to have 
hypoglycemic seizures. Hence a review at the metabolic parameters at 
admission was mandatory and when detected was most rewarding for the 
treating physician. 
Alcohol withdrawl seizures contributed to above 5% of cases in our 
study. History was the most important thing in patients diagnosed to have 
alcohol withdrawl seizures. In the study conducted by Franson KL et al57, 
drug induced seizure in the elderly, alcohol withdrawl seizures was the 
major cause for seizures.  
61 
 
Neoplasm contributed to 4% of cases in our study. All the 4 cases 
were due to secondary metastasis, of the 4 cases, 2 cases had bronchogenic 
carcinoma, 1 patient each had bladder and renal carcinoma. So the patients 
with known primary carcinoma presenting with seizures, the first thing 
which should be ruled out as the cause for seizures is intracranial 
metastasis. 
As already discussed, most of the cases occurred in the age group 
between 60-70 years, which was 52% of total cases. Among 52 % of cases 
in 60-70 years age group, cerebrovascular disease contributed to 30%, 
central nervous system infection in 7%, metabolic causes in 6%, Alcohol 
with drawl in 3% ,toxins in 2% and neoplasm in 4% of cases. 
Seizure type 
The seizure type in our study, classified as per international league 
against epilepsy, revised classification of epileptic seizured, revealed 
partial seizure in 61% and generalized seaizures in 31% of cases. 
In the study conducted by Chung Yung et al58, on epileptic seizures 
in the elderly people, etiology and seizure type, partial seizures was 
observed in 80% and generalized tonic clonic seizures in 20% .Similarly in 
the study conducted by Eugene Ramsay et al3, showed partial seizures in 
73% and generalized tonic clonic seizures in 27% and in the study 
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conducted by Hauser et al, showed partial seizures in 52% and generalized 
tonic clonic seizures in 48%. The observation of seizure type in the above 
mentioned studies showed preponderance of partial seizures, which was 
similar to our study. 
Table23-Comparison of seizure type with other studies 
Seizure type 
Our 
Study 
Hauser  et al Chung Yung 
et al 
Ramsay et al 
Partial 61 80 52 73 
Generalized 39 20 48 27 
 
Among the seizure type observed in cerebrovascular disease 
patients, partial seizures was observed in 82% of patients and generalized 
tonic clonic convulsions in 18%. In the study conducted by Daniel et56 al 
on prevalence and predictors of early seizures and status epilepticus after 
first stroke, partial seizures was seen in 59% of cases and generalized tonic 
clonic convulsions in 41% of cases. 
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Table 24-Comparison of seizures in cerebrovascular  
disease with other study 
Seizure type Daniel et al Our Study 
Partial 59 82 
Generalized 41 18 
 
Incidence of status epilepticus was seen in 27% of the patients in our 
study. In the study conducted by Hauser et al59 on status epilepticus and 
associated morbidity, status epilepticus was observed in 30% of cases in 
acute symptomatic seizures in the elderly group.  
In the study conducted by Sung et al60 on status epilepticus in the 
elderly the incidence of status epilepticus was 30% and similarly in the 
study on incidence of status epilepticus in Rochester minnestoa by 
Hesdorffer et al61 the incidence of status epilepticus was 35% in acute 
onset symptomatic seizures in the elderly group. Among the 27% of status 
epilepticus in our study cerebrovascular disease, contributed to 15% of 
cases, central nervous system infections in 6% cases ,metabolic causes in 
3% of cases, toxin induced causes in 2% and alcohol withdrawl seizures in 
1% of cases.  
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Table 25-Comparison of status epilepticus incidence with other studies  
Status epilepticus Percentage 
Hauser et al  30 
Sung et al  30 
Hesdorffer et al  35 
Our study  27 
 
Among the cerebrovascular disease who presented with seizures 
status epileptcius was seen in 24% of  patients.Similarly in the study 
conducted by Daniel et al56 on status epilepticus in stroke, the incidence of 
status epilepticus was 27% of total cases.  
Table 26-Comparsion of status epilepticus in cerebrovascular disease 
with other study. 
Status epilepticus Percentage 
Daniel et al  27 
Our study 24 
 
Among the non convulsive symptoms, limb weakness was the most 
common symptom reported by the attenders during  admission. It is 
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obvious as the most common cause of seizures in our study group was 
stroke which was 62%. Fever was present in 15 cases, most of the patients 
had central nervous system infections. It is important here to emphasize 
that fever is one of the provocative factor for seizures. Headache was 
present in 15 patients most of the patient presented with headache had 
meningitis.  
Previous history of diabetes mellitus was present in 27 patients, out 
of them 2 patients presented with hypoglycemia induced seizures and 2 
patients with hyperglycemia induced seizures. Seizures due to uremia 
occurs in patient with previous history of chronic kidney disease in 3 
patients. Systemic hypertension and diabetes mellitus occurred in 20 
patients, which is significant risk factor for cerebrovascular disease. 
Among the 4 patient with seizures due to neoplasm, 2 patients had 
presented with  history of bronchogenic carcinoma and 1 patient each of 
bladder and renal cell carcinoma ,it is well known fact that the 
bronchogenic, bladder and renal carcinoma has prediction for 
haematogenous spread into the brain. 
EEG was done in 100 patients in our study group. Abnormal EEG 
was found in 27 patients. The average period from the onset of seizures to 
the recording of EEG was six days. The late referral was due to the time 
taken for the patient stabilization before shifting the patient to EEG room. 
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The yield would have been better if we done earlier.The most common 
abnormality in EEG was focal  slowing in 14 patient, diffuse slowing in 
9% cases. Epileptiform discharges was seen in only 4 patients.  
CT scan brain was done is all patients in the study group, in which 
ischemic infarction was seen in 35 cases, intracerebral haemorrhage in 19 
cases,tuberculoma in 1 case,haemorrhagic infarction in 2 cases, and 
hydrocephalus in 1 case. Cortical atrophy was seen in 15 patients which 
was found in combination with other abnormality. In our study ischemic 
infarction was the most common abnormal findings in CT brain. In the 
study conducted   by Alan Holt et al51 on seizures in elderly in etiology and 
prognosis the most common CT brain finding was ischemic infarction 
which was observed in 46% of patients.  
MRI brain was done in 75 cases. MRI was useful to identify lesions 
which were missed in CT brain in 13 cases. The most common 
abnormality which was detected in MRI, which were missed in CT brain  
were 4 cases each of ischemic infarction and encephalitis, 2 cases of 
tuberculoma and cerebral venous thrombosis were also detected in MRI  
brain which was missed in CT brain. MRI was also very useful in 
improving the details of CT findings.  
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SUMMARY 
          A study on acute symptomatic seizures in the elderly was a cross 
sectional study of 100 patients done in the Rajiv Gandhi Government 
General Hospital, Chennai. The maximum incidence of seizures occurred 
in the age group of 60-70 years which was about 52%. There was 
preponderance of occurrence of seizures in males, which was about 60% of 
total cases. The commonest etiology in the study was cerebrovascular 
disease, which contributed to 62% in our study. The second most common 
cause was central nervous system infections which contributed to 15%. 
Among the cerebrovascular disease, ischemic infarction was the most 
commonest cause, which was observed in 63% of total cerebrovascular 
disease patients. Partial seizures was the most common seizure type 
encountered in our study which was seen in 61%. Status epilepticus was 
seen in 27% of the patients in our study. Limb weakness was the most 
common non convulsive symptom reported. Motor system abnormality 
was the most common total neurological deficit, which was observed in 62 
patients. EEG was abnormal in 27 patients. Ischemic infarction was the 
most common CT Brain abnormality, detected in our study, which was 
seen in 35 patients. MRI Brain was useful in detecting new lesions in 13 
patients which were missed initially in CT Brain. 
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CONCLUSION 
• The maximum incidence of seizures occurred in the age group of 60 
to 70 years in the study.  
• Cerebrovascular disease was the most common etiology observed in 
our study. Among cerebrovascular disease, ischemic cerebral 
infarction was the most common cause. Central nervous system 
infections, was the second most common cause followed by 
metabolic causes in our study. So all efforts should be taken to 
evaluate the patients who presented with seizures in the elderly 
patients to identify the etiology, for accurate management. 
• Partial seizures was the most common seizure type encountered in 
the study.  
• Immediate non contrast CT brain was useful, for emergency 
patients, presenting with seizures to guide appropriate acute 
management. MRI Brain was useful in detecting lesions, which were 
missed in CT Brain. Both CT Brain and MRI Brain were 
indispensable in patients with acute symptomatic seizures in the 
elderly. 
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 Fig -9 EEG WITH BILATERAL EPILEPTIFORM ACTIVITY  
 
Fig -10 EEG WITH GENERALISED SLOW WAVES  
  
Figure-11: MRI Brain- GRE  
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Figure-13: CT Brain         
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Figure-14:MRI Brain 
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Figure-15: MRI Brain- T1 
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Figure-16: MRI Brain- T2 
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Fig – 17: CT Brain Meningitis 
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PATIENT  CONSENT  FORM 
 
STUDY TITLE : A STUDY ON ACUTE  SYMPTOMATIC SEIZURES  IN  THE     
ELDERLY 
Study Centre  : Madras Institute of Neurology, 
                                                          Madras Medical College, Chennai – 600 003 
Patient’s Name  : 
Patient’s Age  : 
Identification Number  :                Patient may check (3 ) these boxes 
I confirm that I have understood the purpose of procedure for the above study. I 
have the opportunity to ask the question and all my questions and doubts have been 
answered to my complete satisfaction. 
 
I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time without giving any reason, without my legal rights being 
affected. 
 
I understand that sponsor of the clinical study, others working on the sponsor’s 
behalf, the ethics committee and the regulatory authorities will not need my 
permission to look at my health records both in respect of the current study and any 
further research that may be conducted in relation to it, even if I withdraw from the 
study. I agree to this access. However, I understand that my identity will not be 
revealed in any information released to third parties or published, unless as required 
under the law. I agree not to restrict the use of any data or results that arise from this 
study. 
 
I agree to take part in the above study and to comply with the instructions given 
during the study and to faithfully co-operate with the study team, and to 
immediately inform the study staff if I suffer from any deterioration in my health or 
well being or any unexpected or unusual symptoms. 
 
I hereby consent to participate in this Study on  acute symptomatic seizures in the 
elderly 
 
I hereby give permission to undergo complete clinical examination and diagnostic 
tests including hematological, biochemical, radiological and urine examination. 
 
Signature / Thumb Impression ___________________ Place _________ Date ____________ 
Patient’s Name and Address: ___________________________________________________ 
Signature of the Investigator : ___________________ Place _________ Date ____________ 
Study Investigator’s Name : ________________________________________________ 
PROFORMA FOR EVALUATION  
 
Name                                                       Age                            Sex  
 
Address  
 
 
 Occupation                                                                Contact  no 
op/ip no                   ward                               DOA                         DOD        
 
min no                    EEG no    
 
Referred from 
ELABORATION OF SEIZURE  
    
Witnesse of seizure                                                                                Reliability  
 
BEFORE THE EPISODE  
     Recent illness ( headache / fever ) 
     Unusual stress  
     Medications 
     Last alcohol intake  
     Last meal    
     Sleep deprivation  
     Activity just before seizure  
     DURING THE EPISODE  
     Time of day  
     Aura  
     Duration  
     Ability to talk & comprehend  
     Ability to recall events  
     Movements of      eyes                  face                arms                  legs  
     Tongue bite                                           frothing 
     Bowel / bladder incontinence  
     Bodily injuries sustained  
 
AFTER EVENT 
     Confusion                          duration 
     Focal neurological deficits    
     Headache 
     Any other significant symptoms 
 
SIGNIFICANT PAST HISTORY 
     Diabetic : yes / no      duration & treatment 
     Hypertension                                              CAD                                 CKD 
     tuberculosis  
     any others   
     
      alcohol intake  y / n       duration                freq                  quantity                    last intake 
      smoking  
     family h/o seizures  
CLINICAL EXAMINATION 
     General exam      
      Neuro cut markers  
     Vitals :    BP              Pulse            RR              Temp 
     CENTRAL NERVOUS SYSTEM EXAMINATION     
     at presentation                                Time after seizure   
     signs of meningial irritation   
     higher functions  
     cranial nerves 
     motor system 
     sensory system                                     
     cerebellum         
     CVS :                                        RS:                                         P/A : 
      
      
     COURSE DURING HOSPITAL STAY 
 
 
  INVESTIGATIONS :  
      
       Hematology       TC :            DC:     P        L      E      B            HB :         ESR:  
         
 
       Biochemistry     
        sugar             urea            creatinine              Na          k        Ca   
 
       CSF analysis    
        
       Others : 
 
      ECG :                                                                           
     Xray Chest: 
     ECHO :  
    CT BRAIN : 
 
    MRI BRAIN :  
 
    EEG :  
   Treatment  
 
 
 
 
 
      
 
S.
N
o
 
Name 
A
g
e
 
S
e
x
 
S
e
i
z
u
r
e
s
 
T
y
p
e
 
S
t
a
t
u
s
 
e
p
i
l
e
p
t
i
c
u
s
 
P
a
s
t
 
H
i
s
t
o
r
y
 
f
e
v
e
r
 
h
e
a
d
a
c
h
e
 
A
l
t
e
r
e
d
 
s
e
n
s
o
r
i
u
m
 
F
N
D
 
B
.
 
s
u
g
a
r
 
B
.
 
u
r
e
a
 
S
 
.
c
r
e
a
t
i
n
i
n
e
 
E
E
G
 
C
T
 
B
r
a
i
n
 
M
R
I
 
B
r
a
i
n
 
Diagnosis 
1. Ravi  67  M  P  2  1  2  2  1  1  A  N  N  A  A  A  ICH 
2. Anandhan  71  M  p  1  0  2  2  2  1  N  N  N  N  A  A  Ischemic Infarction 
3. Parthiban  81  M  P  2  2,4  2  2  2  1  N  N  N  N  A  A  Ischemic Infarction 
4. Durairaj  63  M  G  1  3  2  2  2  1  A  N  N  A  A  A  Ischemic Infarction 
5. Vellaisamy  76  M  G  2    O  2  2  2  1  N  N  N  N  A  A  ICH 
6. Ananthy  61  FM  G  1  7  2  2  2  1  N  N  N  A  A  A  Ischemic Infarction 
7. Anjali  77  FM  P  2  0  2  2  2  1  N  N  N  N  A  A  Ischemic Infarction 
8. Vellaiyan  66  M  P  2  3  2  2  2  1  A  N  N  N  A  A  ICH 
9. Gajendran  67  M  P  2  0  2  2  2  1  N  N  N  N  A  A  Ischemic Infarction 
10. Eswari  84  FM  P  2  2,4  2  2  2  1  N  N  N  N  A  A  ICH 
11. Kalaiarasi  69  FM  P  2  7  2  1  2  1  N  N  N  N  A  B  CVT 
12. Jayapal  76  M  G  1  1  2  2  2  1  A  N  N  A  A  A  Ischemic Infarction 
13. Kuppusamy  60  M  P  2  4  2  2  2  1  N  N  N  N  A  A  ICH 
14. Ganesan  72  M  P  2  2  2  2  1  1  N  N  N  A  A  A  Ischemic Infarction 
15. Megalai  64  F  G  2  3  2  2  2  1  A  N  N  N  A  A  Ischemic Infarction 
16. Nalini  79  F  P  2  1  2  1  2  1  A  N  N  A  N  A  CVT 
17. Ismail  67  M  P  1  0  2  2  2  1  N  N  N  N  A  A  Ischemic Infarction 
18. Chinnasamy  66  M  P  2  2  2  2  2  1  N  N  N  A  A  A  ICH 
19. Bhuvana  75  F  P  2  1  2  2  2  1  A  N  N  N  A  A  Ischemic Infarction 
20. Malar  63  F  G  1  2  2  2  2  1  N  N  N  A  N  A  Ischemic Infarction 
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Diagnosis 
21. Andiappan  83  M  P  2  4  2  2  2  1  N  N  N  N  A  A  Ischemic Infarction 
22. Malliga  76  F  P  2  3  2  2  2  1  A  N  N  N  A  A  ICH 
23. Rajendran  64  M  P  2  0  2  2  1  1  N  N  N  N  A  A  Ischemic Infarction 
24. Arasi  82  F  G  1  7  2  1  2  1  N  N  N  A  N  A  CVT 
25. Kannan  65  M  P  2  0  2  2  2  1  N  N  N  N  A  A  ICH 
26. Padmini  84  F  G  2  3  2  2  2  1  A  N  N  N  A  A  Ischemic Infarction 
27. Nazir  69  M  P  2  0  2  2  2  1  N  N  N  N  A  A  ICH 
28. Chellammal  83  M  P  2  0  2  2  2  1  N  N  N  N  A  A  ICH 
29. Chellam  61  F  P  2  1  2  2  2  1  A  N  N  N  A  A  Ischemic Infarction 
30. Muthammal  82  F  P  2  0  2  2  2  1  N  N  N  N  A  A  Ischemic Infarction 
31. Kumar  63  M  P  1  1  2  2  2  1  A  N  N  A  A  A  Ischemic Infarction 
32. Dhanapal  62  M  P  2  0  2  2  1  1  N  N  N  N  A  A  Ischemic Infarction 
33. Bharani  79  F  P  2  2  2  2  2  1  N  N  N  N  A  A  ICH 
34. Mani  67  M  P  2  1  2  2  2  1  A  N  N  N  A  A  Ischemic Infarction 
35. Kavitha  77  F  P  1  4  2  2  2  1  N  N  N  A  A  A  Ischemic Infarction 
36. Devanayagi  83  F  G  2  2  2  2  2  1  N  N  N  N  A  A  Ischemic Infarction 
37. Ramalingam  65  M  P  2  0  2  2  2  1  N  N  N  N  A  A  ICH 
38. Ravichandran  76  M  P  2  1  2  2  2  1  A  N  N  A  A  A  Ischemic Infarction 
39. Ponnammal  67  F  P  2  0  2  2  2  1  N  N  N  A  A  A  Ischemic Infarction 
40. Rani  74  F  P  2  0  2  2  2  1  N  N  N  N  A  A  ICH 
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Diagnosis 
41. Sampantham  68  M  P  1  3  2  2  2  1  A  N  N  A  A  A  Ischemic Infarction 
42. Prabakaran  85  M  P    2  0  2  2  2  1  N  N  N  N  N  A  Ischemic Infarction 
43. Chamundi  86  F  P  2  2  2  2  2  1  N  N  N  N  A  A  ICH 
44. Manoharan  78  M  P  2  0  2  2  2  1  N  N  N  N  A  A  CVT 
45. Palanivel  70  M  P  2  1  2  2  2  1  A  N  N  A  A  A  Ischemic Infarction 
46. Lakshmi  87  F  G  2  4  2  2  2  1  N  N  N  N  A  A  Ischemic Infarction 
47. Valli  73  F  P  1  0  2  2  1  1  N  N  N  N  N  A  Ischemic Infarction 
48. Bannariammal  63  F  p  2  2  2  2  2  1  N  N  N  N  A  A  ICH 
49. Chinnammal  86  F  P  2  0  2  2  2  1  N  N  N  N  A  A  ICH 
50. Ranganayaki  72  F  P  1  1  2  2  2  1  A  N  N  N  A  A  Ischemic Infarction 
51. Srinivasan  62  M  P  2  0  2  2  2  1  N  N  N  A  A  A  Ischemic Infarction 
52. Bagiyam  61  F  P  2  2  2  2  2  1  N  N  N  A  A  A  Ischemic Infarction 
53. Thiyagarajan  77  M  P  2  1  2  2  2  1  A  N  N  N  A  A   Ischemic Infarction 
54. Gunamani  76  F  P  1  4  2  2  2  1  N  N  N  N  A  A  Ischemic Infarction 
55. Govindhan  63  M  P  2  0  2  2  1  1  N  N  N  A  N  A  Ischemic Infarction 
56. Thulasi  82  F  P  2  1  2  2  2  1  A  N  N  N  A  A  ICH 
57. Shanmugam  76  M  P  1  2  2  2  2  1  N  N  N  N  A  A  Ischemic Infarction 
58. Harikrishnan  77  M  P  2  1  2  2  2  1  A  N  N  A  A  A  Ischemic Infarction 
59. Gnanamalar  79  F  P  1  0  2  2  2  1  N  N  N  N  A  A  ICH 
60. Panneselvam  65  M  P  2  1  2  2  2  1  A  N  N  A  A  A  Ischemic Infarction 
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Diagnosis 
61. Velammal  66  F  P  2  0  2  2  2  1  N  N  N  N  A  A  Ischemic Infarction 
62. Kandhan  68  M  P  2  0  2  2  2  1  N  N  N  N  A  A  ICH 
63. Chinnappan  62  M  P  2  1,7  1  1  2  2  A  N  N  N  A  A  Tuberculoma  
64. Ayyavu  71  M  G  1  0  1  1  1  2  N  N  N  A  N  A   Encephalitis 
65. Kumaresan  61  M  G  2  7  1  1  1  1  N  N  N  N  A  A  Meningitis 
66. Aruna  74  F  G  1  0  1  2  1  2  N  N  N  A  N  A  Encephalitis 
67. Komathi  73  F  G  2  2  1  1  1  1  N  N  N  N  N  B  Meningitis 
68. Vimala  65  F  P  2  7  1  1  1  2  N  N  N  N  N  A  Tuberculoma  
69. Pavai  82  F  G  1  0  1  1  1  2  N  N  N  A  A  A  Meningitis 
70. Alagiri  66  M  G  2  0  1  1  1  2  N  N  N  N  N  B  Meningitis 
71. Dhanapal  67  M  P  2  1  1  1  1  1  A  N  N  N  N  A  Brain Abscess 
72. Ramasamy  84  M  G  1  0  1  1  1  2  N  N  N  A  A  A  Meningitis 
73. Chitra  74  F  G  2  0  1  1  1  2  N  N  N  A  N  B  Meningitis 
74. Loganathan  67  M  G  1  2  1  2  1  2  N  N  N  N  N  A  Encephalitis 
75. Subramanian  76  M  G  2  0  1  1  1  2  N  N  N  N  N  B  Meningitis 
76. Rangammal  68  F  G    1  0  1  1  1  1  N  N  N  N  N  B  Meningitis 
77. Sampath  73  M  G  2  0  1  2  1  2  N  N  N  A  N  A  Encephalitis 
78. Murugan  63  M  G  1  2,5  2  2  1  2  N  A  A  N  N  B  Uremia 
79. Senthil  67  M  P  2  1  2  2  2  2  A  N  N  A  N  B  Hypoglycemia 
80. Ponni  66  F  G  2  1  2  2  2  2  A  N  N  N  N  B  Hypoglycemia 
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Diagnosis 
81. Kodhai  72  F  G  2  1  2  2  2  2  A  N  N  N  N  B  Hyperglycemia 
82. Gandhi  76  F  G  2  2,5  2  2  2  2  N  A  A  N  N  B  Uremia 
83. Kumaravel  82  M  G  1  1  2  2  2  2  A  N  N  N  N  B  Hyperglycemia 
84. Chandrasekar  65  M  P  2  0  2  2  2  2  N  N  N  N  N  B  Hypoglycemia 
85. Vadivu  66  F  G  2  2,5  2  2  2  2  N  A  A  N  N  B  Uremia 
86. Palaniappan  64  M  P  1  1  2  2  2  2  A  N  N  N  N  B  Hypoglycemia 
87. Kalairavan  73  M  G  2  0  2  2  2  2  N  N  N  N  N  B  Hypoglycemia 
88. Sivaraman  63  M  G  1  0  2  2  2  2  N  N  N  N  N  B  Alcohol withdrawl seizures 
89. Thangavel  67  M  G  2  0  2  2  2  2  N  N  N  A  N  B  Alcohol withdrawl seizures 
90. Veerannan  77  M  G  2  0  2  2  2  2  N  N  N  N  N  B  Alcohol withdrawl seizures 
91. Ammasi  82  M  G  2  0  2  2  2  2  N  N  N  N  N  B  Alcohol withdrawl seizures 
92. Babu  65  M  G  2  0  2  2  2  2  N  N  N  N  N  B  Alcohol withdrawl seizures 
93. Papathy  65  F  G  1  0  2  2  2  2  N  N  N  N  N  B  OPC poisoning 
94. Soundarajan  72  M  G  2  0  2  2  2  2  N  N  N  A  N  B  OPC poisoning 
95. Nagendran  68  M  G  2  0  2  2  2  2  N  N  N  N  N  B  OPC poisoning 
96. Gopal  82  M  G  2  0  2  2  2  2  N  N  N  N  N  B  Permethrin poisoning 
97. Vanchilingam  63  M  P  2  0  2  2  2  2  N  N  N  A  A  A  Neoplasm 
98. Mohammed  65  M  P  2  0  2  2  2  2  N  N  N  A  A  A  Neoplasm 
99. Palanisamy  68  M  P  2  0  2  2  2  2  N  N  N  N  A  A  Neoplasm 
100. Rajamani  61  M  P  2  0  2  2  2  2  N  N  N  N  A  A  Neoplasm 
 
KEY TO MASTER CHART 
SEX 
       M-male  ,  F-female 
SEIZURE TYPE 
       P-partial seizure , G-generalized seizures 
STATUS EPILEPTICUS 
      1-present , 2-absent 
PAST HISTORY 
      1-diabetes mellitus,  2-systemic hypertension ,  3- diabetes mellitus  
and systemic hypertension ,   4-coranary artery disease ,  5-chronic kidney 
disease 6-nepolasm,  7-pulmonary tuberculosis ,  0-absent. 
FEVER 
    1-present,  2-absent 
HEAD ACHE 
        1-present,  2-absent 
ALTERED SENSORIUM 
       1-present, 2-absent 
FND(focal neurological deficit) 
       1-present ,2-absent 
BLOOD SUGAR 
      A-Abnormal, N-normal 
BLOODUREA    
      A-Abnormal, N-normal 
BLOOD CREATININE 
      A-Abnormal, N-normal 
EEG 
      A-Abnormal, N-normal 
CT BRAIN 
       A-Abnormal, N-normal 
MRI BRAIN 
      A-Abnormal, N-normal 
      
 
       
 
 
